Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11680068 Compounds useful as RET inhibitors

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
‌
Cancer Research Technology Limited
0
Date Filed
May 6, 2022
0
Date of Patent
June 20, 2023
0
Patent Applicant
‌
Cancer Research Technology Limited
0
Patent Application Number
17738278
0
Patent Citations
‌
US Patent 8796455 Fused bicyclic mTOR inhibitors
0
‌
US Patent 8901134 Pyrazolo [3,4-D] pyrimidine derivatives useful to treat respiratory disorders
0
‌
US Patent 9096611 Kinase inhibitors and methods of use
0
‌
US Patent 9174994 Enhanced treatment regimens using mTor inhibitors
0
‌
US Patent 9271963 Selective inhibitors of human corticosteroid synthases
0
‌
US Patent 9358229 JAK PI3K/mTOR combination therapy
0
‌
US Patent 9409911 Inhibitors of bruton's tyrosine kinase
0
‌
US Patent 9512125 Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents
0
‌
US Patent 9629843 MTOR modulators and uses thereof
0
‌
US Patent 9669032 Enhanced treatment regimens using mTOR inhibitors
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11680068
0
Patent Primary Examiner
‌
Deepak R Rao
0
CPC Code
‌
C07D 487/04
0
‌
A61K 31/519
0
‌
A61P 35/00
0

Find more entities like US Patent 11680068 Compounds useful as RET inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.